ERS Genomics

1 follower

ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner, and Nobel Prize-winner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.

Industries

Employees

11-50

Links


Org chart

Chief Executive Officer
Senior Director Business Development & Licensing EMEA

Board & advisors

Chairman & Co-Founder
Scientific Advisor & Co-Founder
Director & Co-Founder